Stockchase Opinions

John Zechner Docusign DOCU-Q HOLD Apr 29, 2024

It has maxed out to a large degree on the growth side. It is still dominant in the space and could be an acquisition target.

$57.100

Stock price when the opinion was issued

Technology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

DON'T BUY
Wall Street has left certain "pandemic" stocks for dead. They offer a valuable product that will expand its reach. But more business deals will be done face to face after Covid. DOCU is trading at 56x PE even after falling from highs. DOCU flew too high during Covid.
BUY ON WEAKNESS
Downgraded a lot today BOA downgraded it to a sell today, but he added to his holdings today. It's down 80% from its pandemic highs, but its products are everywhere. Not a great investment, sure, but DOCU is an essential part of any business that already uses it, and businesses rarely change their service systems. Also, companies and countries are reacting to the Russian invasion of Ukraine--they're asking, in which country is my data residing? He's in pain, but is averaging down. DOCU is a long-term bet. He's known the management since they were private--he's confident DOCU can pivot. He projects double-digit returns in 18 months.
BUY ON WEAKNESS
Are spectacular buys in the tech space, even pandemic tech winners like Docusign. It just reported a surprise beat and shares are soaring. Post-Covid, it sold off hard and fast, but they still had a business going. Buy during sell-offs.
BUY ON WEAKNESS
Allan Tong’s Discover Picks Taking a step back, DOCU revenues have climbed from $250 million in 2016 to $2.1 billion in its last fiscal year. Meanwhile, cash levels are rising. Flashforward to last week's report in which EPS clocked in at $0.44. That was actually down 6% from a year ago, but higher than the expected $0.42. Also impressing the street were revenues of $622.2 million beating $602 million (a 22% increase YOY). The company issued a rosy forecast of $626 million in revenues vs. the street's $625 million. Read 2 Big Technology Stocks That Are Back for our full analysis.
DON'T BUY

Likes and uses its software, but it's still too close to its post-Covid hangover to buy. There are too many competitors, too.

BUY

Has a new CEO since last year and he's aggressively cut costs. Last month, they reported one of their best quarters in years, but shares didn't get any traction.

DON'T BUY

Dominates this business, but ADBE has entered the space. Stock's gone sideways. Software is not unique, and competition will show up. Perhaps a bigger player like MSFT would buy it and incorporate the technology.

STRONG BUY

Their Q2 earnings beat. A pandemic darling that then crashed. But now it trades at a fair valuation and strong free cash flow. She bought it last September is up 35%. Trades at 16x PE and has a 8% free cash flow yield. Great managers who underpromise, so they will beat their quarter. Has real secular growth.

BUY

Decent earnings lie ahead. Has a 5.5% free cash flow yield.